Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Kathryn J Aikin"'
Autor:
Caroline Rains, Kathryn J. Aikin, Helen W. Sullivan, Bridget J. Kelly, Shirley Liu, Camara Wooten, Jenna Brophy, Susana Peinado, Lauren McCormack, Sandra Crouse Quinn
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Under Sect. 564 of the Federal Food, Drug, and Cosmetic Act, when the US Department of Health and Human Services Secretary issues a declaration based on one of four types of determinations, FDA may authorize an unapproved product
Externí odkaz:
https://doaj.org/article/f391605836bd4c0cba8053bc5a16132d
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155035 (2016)
The volume of prescription drug promotion over time is often measured by assessing changes in ad spending. However, this method obscures the fact that some types of advertising are more expensive than others. Another way to measure the changes in pre
Externí odkaz:
https://doaj.org/article/4c5378f68a9046218187799bfb3633e7
Autor:
Christine Lee, Melanie J. McLean, Caroline J. Huang, Anh Nguyen Zarndt, Kathryn J. Aikin, Paula Rausch, Barbara R. Cohen, Janine Delahanty, Danielle M. Sholly, Wendy I. Slavit, Ewa D. Carlton
Publikováno v:
Journal of Primary Care & Community Health, Vol 12 (2021)
The U.S. encompasses a heterogenous mix of people and health disparities exist for various subpopulations, such as minorities, women, people with limited English proficiency, those with low socioeconomic status, and other underserved groups. Differen
Externí odkaz:
https://doaj.org/article/e6a3e020bea042fbaf5419c5fae70456
Autor:
Kathryn J. Aikin, Vanessa Boudewyns, Kevin R. Betts, Kristen C. Giombi, Ryan S. Paquin, Micaela Brewington, Raahina Malik
Publikováno v:
Health Communication. :1-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdcddbf3106534e3ce41ad40a243232e
https://doi.org/10.1080/10410236.2023.2179717
https://doi.org/10.1080/10410236.2023.2179717
Autor:
Jessica Thompson, Roberta C. Wines, Micaela Brewington, Karen Crotty, Kathryn J. Aikin, Helen Sullivan
Publikováno v:
Journal of Communication in Healthcare. :1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a088e3daf09fb45c4e37c438ef3feb9c
https://doi.org/10.1080/17538068.2022.2150236
https://doi.org/10.1080/17538068.2022.2150236
Autor:
Kathryn J. Aikin, Helen W. Sullivan, Andrew Caporaso, Victoria Hoverman, Ting Yan, Douglas Williams, Jennifer Crafts
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:312-320
FDA regulations state print ads for prescription drugs must provide a true statement of information "in brief summary" describing "side effects, contraindications and effectiveness." To fulfill these requirements, these ads typically display risk inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d253148d4c920f2b3e99cf157f74ac2d
https://doi.org/10.1002/pds.5511
https://doi.org/10.1002/pds.5511
Autor:
Kate Ferriola-Bruckenstein, Mihaela Johnson, Janice Tzeng, Ann Marie Trentacosti, Kathryn J. Aikin, Eric Brodsky, Helen Sullivan, Claudia Squire
Publikováno v:
Res Social Adm Pharm
Background The Prescribing Information (PI) is the US Food and Drug Administration (FDA)'s primary tool for communicating a summary of the essential scientific information needed for the safe and effective use of a prescription drug to healthcare pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367a6cec492a172d9b5d675f5983a01b
https://doi.org/10.1016/j.sapharm.2021.07.028
https://doi.org/10.1016/j.sapharm.2021.07.028
Autor:
Jessica Thompson, Molly Lynch, Helen W. Sullivan, Kathryn J. Aikin, Suzanne Dolina, Micaela Brewington
Publikováno v:
Therapeutic Innovation & Regulatory Science.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc4b26586b3ce4abd8a14027adda2419
https://doi.org/10.1007/s43441-023-00523-3
https://doi.org/10.1007/s43441-023-00523-3
Publikováno v:
Health Mark Q
To fulfill a key regulation pertaining to prescription drug broadcast advertising, a common practice is to present the major risks along with “adequate provision” referencing several sources where audiences can obtain the full product labeling. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df146d284c1ffdcacd648b0a362101a
https://doi.org/10.1080/07359683.2021.1989747
https://doi.org/10.1080/07359683.2021.1989747
Autor:
Kate Ferriola-Bruckenstein, Amie C. O’Donoghue, Victoria M. Scott, Ryan S. Paquin, Vanessa Boudewyns, Kathryn J. Aikin
Publikováno v:
Oncologist
Background Little is known about how physicians interpret data displays that depict preliminary or exploratory clinical data in physician-targeted sales aids for oncology drugs. Using three factorial experiments, we examined whether disclosures of da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7e8d618c3c00c9612a649a72ca9ed3
https://doi.org/10.1002/onco.13972
https://doi.org/10.1002/onco.13972